Progress in neuro-psychopharmacology & biological psychiatry
Apr 10, 2026
BACKGROUND: While elevated symptom severity in obsessive-compulsive disorder (OCD) is associated with a profound clinical burden and escalating psychiatric risks, the underlying large-scale network dynamics remain poorly understood. Electroencephalog... read more
Tuberculosis (TB) remains a major cause of infectious disease mortality. Early diagnosis is crucial for curbing transmission and initiating timely treatment. However, the lack of reliable non-sputum-based diagnostic tools often delays prompt detectio... read more
OBJECTIVE: This study aimed to investigate the association between sarcopenia and spinal cord ischemia (SCI) after fenestrated and branched endovascular aortic repair (F/B-EVAR) using two- and three-dimensional measurements of the psoas and iliopsoas... read more
Central nervous system (CNS) drug discovery faces high attrition rates, long timelines and substantial costs due to complex disease biology and the difficulties in safe drug delivery. Conventional CNS processes remain slow and trial-and-error driven.... read more
Increasing clinical trial protocol complexity, amendments, and challenges around knowledge management create significant burden for trial teams. Structuring protocol content into standard formats has the potential to improve efficiency, support docum... read more
SUMMARY: The rapid growth of genomic data and increasing adoption of long-read sequencing technologies have rendered variant calling one of the most computationally demanding tasks in genomic analysis. Although deep learning-based methods currently o... read more
MOTIVATION: Traditional drug discovery methods are costly and inefficient, while existing deep learning approaches remain limited by task specificity and practical applicability. Accurately modeling protein-molecule interactions is critical for advan... read more
Academic medicine : journal of the Association of American Medical Colleges
Apr 10, 2026
Artificial intelligence (AI) is transforming graduate medical education (GME), yet formal training in its responsible use remains limited. As AI capabilities expand, trainees increasingly adopt these tools informally and without structured oversight,... read more
Emerging infectious diseases are one of the most significant threats to global health, driven by many factors such as zoonotic spillovers, climate change, globalization, and antibiotic resistance. While a great deal of attention is focused on viral a... read more
European journal of medicinal chemistry
Apr 9, 2026
Predicting absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles early in drug discovery is essential to avoid late-stage failures. However, most current computational models depend on single-view molecular representations. T... read more
Stay Ahead of Medical AI
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.